[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526929":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":40,"responsibleParty":60,"collaborators":62,"id":64,"slug":18,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":18,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":18,"overallStatus":43,"whyStopped":18,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Genomic Prediction Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental Arm - Transfer of Best Quality, Euploid Blastocyst","EXPERIMENTAL","Transfer of best quality, PGTA normal (euploid) blastocyst.",[13],"Other: Preimplantation genetic testing for aneuploidy (PGTA)",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Arm - Transfer of Untested, Best Quality Blastocyst","NO_INTERVENTION","Transfer of Untested, Best Quality Blastocyst",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"OTHER","Preimplantation genetic testing for aneuploidy (PGTA)","24 chromosome screening for aneuploidy in the preimplantation embryo(blastocyst stage)",[9],[26],{"name":27,"affiliation":28,"role":29},"Nathan Treff, PhD","Genomic Prediction Clinical Labortory","PRINCIPAL_INVESTIGATOR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Talia Metzgar","CONTACT","(973) 529- 4223","talia@genomicprediction.com",{"name":37,"role":33,"phone":38,"phoneExt":18,"email":39},"Kristin Rooney","(781) 434-6500","krooney@bostonivf.com",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Boston IVF","RECRUITING","Waltham","Massachusetts","02451","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-71.23561,42.37649,{"lat":53,"lon":52},[56,58],{"name":37,"role":33,"phone":38,"phoneExt":18,"email":57},"krooney@bivf.com",{"name":59,"role":29,"phone":18,"phoneExt":18,"email":18},"Kim Thorton, MD",{"type":61,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[63],{"name":42,"class":21},"100526929",false,"NCT06141135","GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial","GETSET","Inclusion Criteria:\n\n* Women undergoing IVF of between 35 and 40 years of age at IVF cycle start\n* Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF\n* Utilization of ejaculated or testicular sperm\n* Utilization of autologous or donor sperm\n* All Controlled Ovarian Hyperstimulation (COH) protocols\n\nExclusion Criteria:\n\n* Utilization of donor oocytes\n* Utilization of gestational carrier\n* Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages\n* Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers\n* Preimplantation genetic testing for monogenic\u002Fsingle gene disorders (PGT-M)\n* Translocation carriers","FEMALE","35 Years","40 Years",{"count":74,"type":75},240,"ESTIMATED","INTERVENTIONAL",[78],"NA","The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.",[81],"Infertility, Female","2025-08-19",{"date":84,"type":85},"2025-08-26","ACTUAL",{"date":87,"type":85},"2023-11-15",{"date":89,"type":75},"2026-11-15",{"name":5,"class":6},1]